Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-03

Clinical Trial Update: Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update on biological-guided metronomic chemotherapy as maintenance therapy for metastatic colorectal cancer; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ruijin Hospital | Conditions: Colorectal Cancer | Phase 2, Phase 3 | Status: TERMINATED